Viewing Study NCT02041195


Ignite Creation Date: 2025-12-24 @ 1:31 PM
Ignite Modification Date: 2026-02-22 @ 5:23 PM
Study NCT ID: NCT02041195
Status: COMPLETED
Last Update Posted: 2023-08-07
First Post: 2014-01-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients
Sponsor: Rhythm Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Overweight and Obesity View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Overweight View